4Brassai A, Suvanjeiev RG, Ban EG, et al. Role of synaptic and nonsynaptic glutamate receptors in ischaemia induced neurotoxicitv[J]. Brain Res Bull. 2015.112: 1-6.
5Boger RH, Ron ES. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor[J]. Altem Med Rev, 2005, 10(1): 14-23.
6Na JO, Seo HS, Choi CU, et al. Results of a 14-Week, multicenter, prospective, randomized, Open-Label, noninferiority clinical trial comparing the antihypertensive effect and edema incidence of lacidipine and amlodipine in older korean patients with Mild-to-Moderate hypertension[J]. Curr Ther Res Clin Exp, 2013, 74: 54-61.
7Poole-Wilson PA, Lubsen J, Kirwan BA, et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial[J]. Lancet, 2004, 364(9437): 849-857.
8Ruilope L, Schaefer A. The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertension[J]. Adv Ther, 2013, 30(12): 1086-1099.
9Lubsen J, Wagener G, Kirwan BA, et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial[J]. J Hypertens, 2005, 23(3): 641-648.
10Pasupuleti MK, Musalaiah SV, Nagasree M, et al. Combination of inflammatory and amlodipine induced gingival overgrowth in a patient with cardiovascular disease[J]. Avicenna J Med, 2013, 3(3): 68-72.
